An economic model of the costutility of preemptive genetic testing to support pharmacotherapy in patients with major depression in primary care

An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care

03:57 EST 16 Jan 2019 | Nature Publishing

More From BioPortfolio on "An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care"